Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2016 Mar;151(3):706-707.
doi: 10.1016/j.jtcvs.2015.09.058. Epub 2015 Sep 24.

Risk calculators are useful but..

Xiaofei Wang  1 , Mark F Berry  2
Affiliations
Editorial

Risk calculators are useful but..

Xiaofei Wang et al. J Thorac Cardiovasc Surg. 2016 Mar.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group Ann Thorac Surg. 1995;60:615–622. - PubMed
    1. Wright CD, Gaissert HA, Grab JD, O'Brien SM, Peterson ED, Allen MS. Predictors of prolonged length of stay after lobectomy for lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk-adjustment model. Ann Thorac Surg. 2008;85:1857–1865. - PubMed
    1. Samson P, Robinson CG, Bradley J, Lee A, Broderick A, Kreisel D, et al. The National Surgical Quality Improvement Program (NSQIP) Risk Calculator Does Not Adequately Stratify Risk for Clinical Stage I Non-Small Cell Lung Cancer. J Thorac Cardiovasc Surg. 2015 - PMC - PubMed
    1. Altorki NK, Yip R, Hanaoka T, Bauer T, Aye R, Kohman L, et al. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. J Thorac Cardiovasc Surg. 2014;147:754–762. - PubMed
    1. Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015;16:630–7. - PMC - PubMed